Human endogenous retrovirus-K(II) envelope induction protects neurons during HIV/AIDS

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Bhat, Rakesh K ^a   Rudnick, Wallis ^a   Antony, Joseph M ^a   Maingat, Ferdinand ^a   Ellestad, Kristofor K ^a   Wheatley, Blaise M ^a   Tönjes, Ralf R ^b   Power, Christopher ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; NERVE GROWTH FACTOR; RAG1 PROTEIN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN K 2; VPR PROTEIN; HOMEODOMAIN PROTEIN; RAG-1 PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BDNF GENE; BRAIN CELL CULTURE; BRAIN CORTEX; CELL VIABILITY; COGNITION; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; ENVELOPE GENE; FETUS; GENE EXPRESSION; GENE PRODUCT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; MOUSE; NEURAL STEM CELL; NEUROPROTECTION; NEUROTOXICITY; NGF GENE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; ANIMAL; CELL CULTURE; CYTOLOGY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; NERVE CELL; PATHOGENICITY; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION; VIROLOGY;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; CEREBRAL CORTEX; ENDOGENOUS RETROVIRUSES; EPIDERMAL GROWTH FACTOR; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTOR; NEURAL STEM CELLS; NEURONS; SEQUENCE ANALYSIS, DNA; UP-REGULATION; VIRAL ENVELOPE PROTEINS; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84903793322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097984     Document Type: Article

References (59)

1. Becker Y (1995) Endogenous retroviruses in the human genome-a point of view. Virus genes 9: 211-218.
2. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921. (Pubitemid 32165345)
3. Bannert N, Kurth R (2004) Retroelements and the human genome: new perspectives on an old relation. Proc Natl Acad Sci U S A 101 Suppl 2: 14572-14579. (Pubitemid 39346726)
4. Paces J, Pavlicek A, Paces V (2002) HERVd: database of human endogenous retroviruses. Nucleic acids research 30: 205-206. (Pubitemid 34679543)
5. Weiss RA (2006) The discovery of endogenous retroviruses. Retrovirology 3: 67.
6. Deslauriers AM, Afkhami-Goli A, Paul AM, Bhat RK, Acharjee S, et al. (2011) Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration. Journal of immunology 187: 4788-4799.
7. Bhat RK, Ellestad KK, Wheatley BM, Warren R, Holt RA, et al. (2011) Age- and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression. PloS one 6: e19176.
8. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, et al. (1999) Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Current biology: CB 9: 861-868.
9. Mallet F, Prudhomme S (2004) [Retroviral inheritance in man]. Journal de la Societe de biologie 198: 399-412.
10. Reynier F, Verjat T, Turrel F, Imbert PE, Marotte H, et al. (2009) Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scandinavian journal of immunology 70: 295-299.
11. Douville R, Liu J, Rothstein J, Nath A (2011) Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Annals of neurology 69: 141-151.
12. McCormick AL, Brown RH Jr, Cudkowicz ME, Al-Chalabi A, Garson JA (2008) Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 70: 278-283. (Pubitemid 351156807)
13. Belshaw R, Dawson AL, Woolven-Allen J, Redding J, Burt A, et al. (2005) Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. Journal of virology 79: 12507-12514. (Pubitemid 41346113)
14. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, et al. (2001) Insertional polymorphisms of full-length endogenous retroviruses in humans. Current biology: CB 11: 1531-1535.
15. Tonjes RR, Boller K, Limbach C, Lugert R, Kurth R (1997) Characterization of human endogenous retrovirus type K virus-like particles generated from recombinant baculoviruses. Virology 233: 280-291. (Pubitemid 27314815)
16. Contreras-Galindo R, Lopez P, Velez R, Yamamura Y (2007) HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 23: 116-122. (Pubitemid 46214180)
17. Lower R, Lower J, Kurth R (1996) The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proceedings of the National Academy of Sciences of the United States of America 93: 5177-5184. (Pubitemid 26159422)
18. Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF (2000) Endogenous retroviruses and schizophrenia. Brain research Brain research reviews 31: 193-199. (Pubitemid 30136176)
19. Crow TJ (1987) Integrated Viral Genes as Potential Pathogens in the Functional Psychoses. Journal of Psychiatric Research 21: 479-485.
20. Christensen T (2010) HERVs in Neuropathogenesis. Journal of Neuroimmune Pharmacology 5: 326-335.
21. Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, Sheehy ME, Ortiz GM, et al. (2006) Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS research and human retroviruses 22: 52-56. (Pubitemid 43201518)
22. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, et al. (2001) Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Annals of neurology 50: 434-442. (Pubitemid 32938886)
23. Maeda N, Palmarini M, Murgia C, Fan H (2001) Direct transformation of rodent fibroblasts by jaagsiekte sheep retrovirus DNA. Proceedings of the National Academy of Sciences of the United States of America 98: 4449-4454. (Pubitemid 32294997)
24. Palmarini M, Sharp JM, De las Heras M, Fan H (1999) Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep. Journal of virology 73: 6964-6972. (Pubitemid 29327880)
25. Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, et al. (2012) Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. Journal of virology 86: 262-276.
26. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y (2006) Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS research and human retroviruses 22: 979-984. (Pubitemid 46100682)
27. Frendo JL, Olivier D, Cheynet V, Blond JL, Bouton O, et al. (2003) Direct involvement of HERV-W env glycoprotein in human trophoblast cell fusion and differentiation. Molecular and Cellular Biology 23: 3566-3574. (Pubitemid 36539189)
28. McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Annals of neurology 67: 699-714.
29. Herbein G, O'Brien WA (2000) Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine 223: 241-257. (Pubitemid 30337778)
30. Cheeran MC, Hu S, Sheng WS, Peterson PK, Lokensgard JR (2003) CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. Journal of virology 77: 4502-4515. (Pubitemid 36402801)
31. Acharjee S, Noorbakhsh F, Stemkowski PL, Olechowski C, Cohen EA, et al. (2010) HIV-1 viral protein R causes peripheral nervous system injury associated with in vivo neuropathic pain. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 24: 4343-4353.
32. Garrison KE, Jones RB, Meiklejohn DA, Anwar N, Ndhlovu LC, et al. (2007) T cell responses to human endogenous retroviruses in HIV-1 infection. PLoS pathogens 3: e165.
33. Nixon DF, Townsend AR, Elvin JG, Rizza CR, Gallwey J, et al. (1988) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336: 484-487.
34. Sacha JB, Kim IJ, Chen L, Ullah JH, Goodwin DA, et al. (2012) Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic. J Immunol 189: 1467-1479.
35. Antony JM, Izad M, Bar-Or A, Warren KG, Vodjgani M, et al. (2006) Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. AIDS research and human retroviruses 22: 1253-1259. (Pubitemid 46095243)
36. Antony JM, Zhu Y, Izad M, Warren KG, Vodjgani M, et al. (2007) Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis. AIDS research and human retroviruses 23: 1251-1256. (Pubitemid 350014759)
37. Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, et al. (2007) The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. Journal of immunology 179: 1210-1224.
38. Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, et al. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nature neuroscience 7: 1088-1095. (Pubitemid 41184449)
39. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C (2011) Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochimica et biophysica acta 1812: 162-176.
40. Fuchs NV, Kraft M, Tondera C, Hanschmann KM, Lower J, et al. (2011) Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. Journal of virology 85: 3436-3448.
41. van der Kuyl AC (2012) HIV infection and HERV expression: a review. Retrovirology 9: 6.
42. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, et al. (1999) Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. Journal of immunology 163: 3963-3968. (Pubitemid 29450925)
43. Moonen G, Malgrange B, Rigo JM, Rogister B (1996) Neurotrophic factors: past and future. Acta neurologica Belgica 96: 203-218.
44. Yamada M, Hatanaka H (1994) Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain research 643: 173-180. (Pubitemid 24115091)
45. Kristiansen OP, Mandrup-Poulsen T (2005) Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54 Suppl 2: S114-124.
46. St Hillaire C, Vargas D, Pardo CA, Gincel D, Mann J, et al. (2005) Aquaporin 4 is increased in association with human immunodeficiency virus dementia: implications for disease pathogenesis. J Neurovirol 11: 535-543. (Pubitemid 43123772)
47. Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, LeBlanc A, et al. (2010) MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 24: 1799-1812.
48. van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, et al. (2004) Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329: 302-318. (Pubitemid 39423980)
49. Na H, Acharjee S, Jones G, Vivithanaporn P, Noorbakhsh F, et al. (2011) Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence. Retrovirology 8: 44.
50. Ryder EF, Snyder EY, Cepko CL (1990) Establishment and characterization of multipotent neural cell lines using retrovirus vector-mediated oncogene transfer. Journal of neurobiology 21: 356-375. (Pubitemid 20108088)
51. Snyder EY, Deitcher DL, Walsh C, Arnold-Aldea S, Hartwieg EA, et al. (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68: 33-51.
52. Snyder EY (1995) Immortalized neural stem cells: insights into development; prospects for gene therapy and repair. Proceedings of the Association of American Physicians 107: 195-204.
53. Kim DE, Tsuji K, Kim YR, Mueller FJ, Eom HS, et al. (2006) Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging. Radiology 241: 822-830. (Pubitemid 46190549)
54. Vivithanaporn P, Maingat F, Lin LT, Na H, Richardson CD, et al. (2010) Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity. PloS one 5.
55. Jones GJ, Barsby NL, Cohen EA, Holden J, Harris K, et al. (2007) HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. Journal of Neuroscience 27: 3703-3711. (Pubitemid 46557688)
56. Silva C, Zhang K, Tsutsui S, Holden JK, Gill MJ, et al. (2003) Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Annals of neurology 54: 605-614. (Pubitemid 37346067)
57. Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, et al. (2003) Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 53: 731-742. (Pubitemid 36622510)
58. DAVID Database for Annotation V, and Integrated Discovery. Available: http://david.abcc.ncifcrf.gov/.
59. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome biology 4: P3.